Extraordinary Event. ARTICLE 10.1 The Company agrees not to enter into a merger, recapitalization, sale or change of control of the Company or sale transaction involving all or substantially all of the Company’s equity or assets unless the acquiring or successor entity agrees in writing to recognize the Purchaser’s rights under this Purchaser Royalty Agreement.
Appears in 2 contracts
Sources: Purchaser Royalty Agreement (Nutralife Biosciences, Inc), Royalty Participation Agreement (Nutralife Biosciences, Inc)
Extraordinary Event. ARTICLE 10.1 8.1 The Company agrees not to enter into a merger, recapitalization, sale or change of control of the Company or sale transaction involving all or substantially all of the Company’s equity or assets unless the acquiring or successor entity agrees in writing to recognize the PurchaserPledgor’s rights under this Purchaser Pledgor Royalty Agreement.
Appears in 2 contracts
Sources: Royalty Participation Agreement (Nutralife Biosciences, Inc), Royalty Agreement (Nutralife Biosciences, Inc)
Extraordinary Event. ARTICLE 10.1 The Company agrees not to enter into a merger, recapitalization, sale or change of control of the Company or sale transaction involving all or substantially all of the Company’s equity or assets unless the acquiring or successor entity agrees in writing to recognize the PurchaserInvestor’s rights under this Purchaser Royalty Agreement.
Appears in 1 contract
Sources: Royalty Participation Agreement (Auriga Laboratories, Inc.)
Extraordinary Event. ARTICLE 10.1 The Company agrees not to enter into a merger, recapitalization, sale or change of control of the Company or sale transaction involving all or substantially all of the Company’s equity or assets unless the acquiring or successor entity agrees in writing to recognize the PurchaserInvestor’s rights under this Purchaser Royalty Agreement.
Appears in 1 contract
Sources: Royalty Participation Agreement (Auriga Laboratories, Inc.)